Walgreens Boots Alliance

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Trading Performance

Ulcer Index

Score

0.5

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 36 14.4 0.61% 1.38% 2.5% -3.9% -7.4%
SHORT 36 7.7 0.67% 1.33% 2.3% -1.4% 30.7%

Summary

Technical Analysis

Walgreens Boots Alliance (WBA)


Indicator:

ULCER INDEX


Last Signal:

BEARISH


Trading: SELL @ $52.5
Signal Strength: MEDIUM
Recommendation:

Volatility indicators highlight potential moves of a stock which can either move sharply in the updwards or downwards direction. This indicator allows stocks to be compared on a level playing field to highlight high and low volatility. Normally, falling markets are more likely to be volatile than a rising markets due to the emotion that gets tied to trading. Use volatility indicators in conjunction with other indicators to reduce exposure to false moves.


Walgreens Boots Alliance (NASDAQ:WBA) UIX index implies that the downside risk of the current trading price is low. Currently, the UIX is 2.713.



A technical indicator that measures downside risk in terms of both depth and duration of price declines. The Ulcer Index (UI) increases in value as the price moves farther away from a recent high and falls as the price rises to new highs. The indicator is usually calculated over 14 days with the UI showing the percentage drawdown a trader can expect from the high over that period. The greater the value of the UI the longer it takes for a stock to get back to the former high.

Calculation: Ulcer Index:
1) Percentage Drawdown = [(Close - 14-period High Close)/14-period High Close] x 100;
2) Squared Average = (14-period Sum of Percentage Drawdown Squared)/14;
3) Ulcer Index = Square Root of Squared Average;


PROFILE: Walgreens Boots Alliance (WBA)


Stock Exchange: NASDAQ
Company: Walgreens Boots Alliance
Ticker Codes: | WBA | NASDAQ:WBA |

About Walgreens Boots Alliance (NASDAQ:WBA):

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics. It also provides specialty pharmacy services and mail services; and manages in-store clinics. As of August 31, 2017, this segment operated 8,100 retail stores under the Walgreens and Duane Reade brands in the United States; and 7 specialty pharmacies, as well as approximately 400 in-store clinic locations. The Retail Pharmacy International segment sells prescription drugs; and health, beauty, toiletry, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,722 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 637 optical practices, including 178 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in France, the United Kingdom, Germany, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Top 10:

Ulcer Index

Download
Company Close Change(%) Volume Value Signal
UEPS Net 1 UEPS Technologies 3.88 11.8 496,618 12.88 BEARISH
BLCM Bellicum Pharma 2.22 8.8 532,809 12.08 BEARISH
RARX Ra Pharmaceuticals Inc 25.51 8.1 1,293,513 5.64 BEARISH
NVAX Novavax Inc 5.63 5.2 478,406 11.18 BEARISH
KPTI Karyopharm Therapeutics 6.43 4 793,430 6.65 BEARISH
CLLS Cellectis 15.21 4 179,537 5.18 BEARISH
HONE Harborone Bancorp 18.4 3.3 228,037 5.29 BEARISH
ITCI Intra-Cellular 13.28 2.9 983,825 8.89 BEARISH
USLM US Lime & Mineral 84.22 2.7 5,244 7.09 BEARISH
CRSP Crispr Therapeutics 45.41 2.4 869,445 6.97 BEARISH